Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Leonel A Torres Aroche"'
Autor:
Alejandro Perera Pintado, Leonel A. Torres Aroche, Alex Vergara Gil, Juan F. Batista Cuéllar, Anaís Prats Capote
Publikováno v:
Nucleus, Vol 0, Iss 62, Pp 2-9 (2017)
SPECT/CT has represented not only the possibility of acquiring anatomical and functional images in one single study, but also a revolution for the clinical management of several diseases, taking the better of each one of these imaging modalities. The
Externí odkaz:
https://doaj.org/article/a4d4a45cb7b84891998ddb0af684d070
Autor:
Adlín López Díaz, Reysel Reynosa Montejo, Aley Palau San Pedro, Juan Miguel Martín Escuela, Leonel Alberto Torres Aroche
Publikováno v:
Nucleus, Vol 0, Iss 61, Pp 16-20 (2017)
Optimization and verification of Specific Patient Treatment Planning with unsealed 131I sources in hyperthyroidism diseases is a desirable goal from medical and radiation protection viewpoints. In order to verify the estimation of patient’s specifi
Externí odkaz:
https://doaj.org/article/04961544a9e2403eac897739f88d6a3e
Autor:
Leonel Alberto Torres-Aroche, Saily Sosa-Pérez, Chryslaine Rodríguez-Tanty, Yamilé Peña-Quián, Elvia Luz-Sánchez, Susana Romero-Collado, Juan Felipe Batista-Cuéllar
Publikováno v:
MEDICC review. 23(1)
Introduction Alzheimer disease is related to several risk factors including aging, family history, high blood pressure and diabetes. Studies have shown specific regional cerebral perfusion changes in patients with Alzheimer disease. Some authors stat
Autor:
Roberto Fraxedas Mayor, Gladys M. López Bejerano, Adlin López, Leonel A. Torres Aroche, Consuelo Varela Corona, Marco A. Coca Perez
Publikováno v:
Journal of Nuclear Medicine Technology. 36:203-206
Monitoring the quality of instrumentation used in nuclear medicine is mandatory to guarantee the clinical efficacy of medical practice. A national program for the quality control of nuclear medicine instruments was established in Cuba and was certifi
Autor:
Leonel A Torres Aroche, Juan P. Oliva, Obaya T Rodríguezi, Maria Cordero, Mayra Ramos-Suzarte, Joaquín González, Rodriguez Rolando Perez, Gilmara Pimentel, Normando Iznaga-Escobar, Ramos Tania Crombet, Nelson Rodriguez Mesa, Alejandro P Pintado
Publikováno v:
Cancer biologytherapy. 6(1)
Monoclonal antibody (mAb) ior c5 is an IgG1, which recognizes a glycoprotein tumor specific antigen IOR C2 over expressed in the surface of colon and ovarian cancer cells. The aim of the present work was to evaluate the diagnostic efficacy of the 99m